You are here: Home » Reuters » News
Business Standard

Drugmaker Dr. Reddy's third-quarter profit rises 65.3 percent, beats estimates


(Reuters) - Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted a 65.3 percent surge in quarterly profit on Friday, driven by strong growth in emerging markets.Third-quarter net profit came in at 5 billion rupees ($70.10 million), compared with 3.03 billion rupees a year earlier, the company said.Analysts on average expected the Hyderabad-based company to post a profit of 3.94 billion rupees, according to Refinitiv data.($1 = 71.3300 rupees) (Reporting by Chandini Monnappa in BENGALURU; Editing by Christopher Cushing)(This story has not been edited by Business Standard staff and is ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Fri, February 01 2019. 15:08 IST